(Q34532577)

2 August 2017

1 reference

title

Assessing risks for a pre-emergent pathogen: virginiamycin use and the emergence of streptogramin resistance in Enterococcus faecium (English)

1 reference

2 August 2017

Enterococcus faecium

1 reference

D L Smith

1

1 reference

2 August 2017

J A Johnson

2

1 reference

2 August 2017

A D Harris

3

1 reference

2 August 2017

J P Furuno

4

1 reference

2 August 2017

E N Perencevich

5

1 reference

2 August 2017

J G Morris

6

1 reference

2 August 2017

language of work or name

1 reference

1 April 2003

1 reference

Lancet Infectious Diseases

2 August 2017

published in

1 reference

2 August 2017

volume

3

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

241-249

1 reference

Emergence of vancomycin-resistant enterococci

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Occurrence and epidemiology of resistance to virginiamycin and streptogramins

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

In vitro susceptibility of Enterococcus faecium isolated from food to growth-promoting and therapeutic antibiotics.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Antibiotics in agriculture: when is it time to close the barn door?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Animal antibiotic use has an early but important impact on the emergence of antibiotic resistance in human commensal bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Understanding the spread of antibiotic resistant pathogens in hospitals: mathematical models as tools for control

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Transmission dynamics of epidemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Vancomycin-resistant enterococci in intensive-care hospital settings: transmission dynamics, persistence, and the impact of infection control programs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Vancomycin-resistant enterococci in intensive care hospital settings

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

The transmission dynamics of antibiotic-resistant bacteria: the relationship between resistance in commensal organisms and antibiotic consumption.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Prevalence of colonization with vancomycin-resistant enterococci in various population groups in Berlin, Germany

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Prevalence of vancomycin-resistant enterococci in fecal samples from hospitalized patients and nonhospitalized controls in a cattle-rearing area of France

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Comparison of glycopeptide-resistant Enterococcus faecium isolates and glycopeptide resistance genes of human and animal origins

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Epidemiology of vancomycin-resistant enterococci in the community and the relevance of farm animals to human infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Selective pressure by antibiotic use in livestock

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Vancomycin-resistant enterococci: why are they here, and where do they come from?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Implications of multiple antimicrobial-resistant enterococci associated with the poultry environment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Comparative in vitro activity of quinupristin/dalfopristin against multidrug resistant Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

In-vitro and in-vivo antibacterial activity of quinupristin/dalfopristin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Evaluation of in vitro activity of quinupristin/dalfopristin and comparator antimicrobial agents against worldwide clinical trial and other laboratory isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Susceptibility to RPR 106,972, quinupristin/dalfopristin and erythromycin among recent clinical isolates of enterococci, staphylococci and streptococci from North American medical centres

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Susceptibility to quinupristin/dalfopristin and other antibiotics of vancomycin-resistant enterococci from the UK, 1997 to mid-1999.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Characterization of isolates associated with emerging resistance to quinupristin/dalfopristin (Synercid) during a worldwide clinical program

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Characterization of a new enterococcal gene, satG, encoding a putative acetyltransferase conferring resistance to Streptogramin A compounds.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Differences in antibiotic resistance patterns of Enterococcus faecalis and Enterococcus faecium strains isolated from farm and pet animals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

High-frequency recovery of quinupristin-dalfopristin-resistant Enterococcus faecium isolates from the poultry production environment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Prevalence of streptogramin resistance genes among Enterococcus isolates recovered from retail meats in the Greater Washington DC area.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Identification of vat(E) in Enterococcus faecalis isolates from retail poultry and its transferability to Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Detection of the satA gene and transferability of virginiamycin resistance in Enterococcus faecium from food-animals.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

satG, conferring resistance to streptogramin A, is widely distributed in Enterococcus faecium strains but not in staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Variation within the vat(E) allele of Enterococcus faecium isolates from retail poultry samples

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Movable genetic elements and antibiotic resistance in enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Transient intestinal carriage after ingestion of antibiotic-resistant Enterococcus faecium from chicken and pork.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Antibiotic resistance of faecal enterococci in poultry, poultry farmers and poultry slaughterers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Transmission of VanA-type vancomycin-resistant enterococci and vanA resistance elements between chicken and humans at avoparcin-exposed farms.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Linkage of determinants for streptogramin A, macrolide-lincosamide-streptogramin B, and chloramphenicol resistance on a conjugative plasmid in Enterococcus faecium and dissemination of this cluster among streptogramin-resistant enterococci.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Quinupristin/dalfopristin-resistant enterococci of the satA (vatD) and satG (vatE) genotypes from different ecological origins in Germany.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Different levels of genetic homogeneity in vancomycin-resistant and -susceptible Enterococcus faecium isolates from different human and animal sources analyzed by amplified-fragment length polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Occurrence of the vancomycin-resistant genes vanA, vanB, vanCl, vanC2 and vanC3 in Enterococcus strains isolated from poultry and pork

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Streptogramin resistance and shared pulsed-field gel electrophoresis patterns in vanA-containing Enterococcus faecium and Enterococcus hirae isolated from humans and animals in Spain.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Host specificity of vancomycin-resistant Enterococcus faecium.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Population biology of infectious diseases: Part I

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Controlling antimicrobial resistance in hospitals: infection control and use of antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

How to assess the relative importance of different colonization routes of pathogens within hospital settings

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Impact of quinupristin/dalfopristin (RP59500) on the faecal microflora in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

The pharmacokinetics of quinupristin/dalfopristin in laboratory animals and in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Effect of parenteral antibiotic administration on the establishment of colonization with vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Antimicrobial susceptibility of 471 enterococcal strains responsible for infections at 101 French hospitals. Collège de Bactériologie, Virologie, Hygiène des Hôpitaux

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Stool colonization with vancomycin-resistant enterococci in healthcare workers and their households

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

Patients in long-term care facilities: a reservoir for vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2803%2900581-4

7 January 2021

10.1016/S1473-3099(03)00581-4

Identifiers

DOI

1 reference

2 August 2017

1 reference